Retrospective Identification and Quantitative Image Analysis of the <scp>ICAP</scp> Nuclear Pattern <scp>AC</scp> ‐30 in Antinuclear Antibody Testing

BACKGROUND: The International Consensus on ANA Patterns (ICAP) recently codified the AC-30 nuclear pattern, characterized by fine speckled nuclear texture and metaphase chromatin staining. Although formally recognized, its clinical significance remains unclear. Quantitative methods and objective outcome measures for characterizing AC-30 have not been established. METHODS: A retrospective analysis was conducted using archived HEp-2 ANA images. AC-30 was defined by unanimous scoring from three blinded experts. AC-1 and AC-2 served as comparator sets. Clinical diagnoses and serological data were retrieved from hospital records. Pixel classification was performed using ilastik, and per-nucleus intensity features were extracted with CellProfiler. Image-level separation was assessed by partitioning nuclei into high- and low-intensity groups via Isolation Forest. Statistical comparisons used Welch's t-tests and Spearman's rank correlation. RESULTS: The AC-30 group included 183 images (AC-1, n = 183; AC-2, n = 207). Within AC-30, 57.4% had non-AID or unknown diagnoses, 26.8% had other autoimmune diseases, and 15.8% had ANA-associated rheumatic disease (AARD). In ENA-negative AC-30, AARD accounted for 7.7% (6/78), compared to 18.3% (21/115) in ENA-negative AC-2. RA accounted for 16.9% (31/183) in AC-30, consistent across ENA strata. AC-30 displayed lower per-nucleus intensities than AC-2 (all p < 0.0001) and reduced per-image ΔMaxIntensity (0.177 vs. 0.252, p < 0.0001), while ΔMeanIntensity was similar (0.068 vs. 0.067, p = 0.549). CONCLUSIONS: AC-30 is quantitatively dimmer than AC-2, with reduced nuclear brightness and peak-intensity separation. In this retrospective cohort, ENA-negative AC-30 was associated with fewer AARD cases. RA accounted for ~17% of AC-30, and anti-CCP and RF remained informative markers. The ilastik-CellProfiler workflow enables auditable ANA quantification.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Laboratory Analysis
Published
2026-05-22
DOI
https://doi.org/10.1002/jcla.70249
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing

Wenhan Du, Weidong Chen, Linlin Xu, Juan He et al.
Journal of Clinical Laboratory Analysis
Systemic Lupus Erythematosus Research
article

Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing

Wenhan Du, Weidong Chen, Linlin Xu, Juan He, Yu Li, Changmeng Wu
article en

Abstract

BACKGROUND: The International Consensus on ANA Patterns (ICAP) recently codified the AC-30 nuclear pattern, characterized by fine speckled nuclear texture and metaphase chromatin staining. Although formally recognized, its clinical significance remains unclear. Quantitative methods and objective outcome measures for characterizing AC-30 have not been established. METHODS: A retrospective analysis was conducted using archived HEp-2 ANA images. AC-30 was defined by unanimous scoring from three blinded experts. AC-1 and AC-2 served as comparator sets. Clinical diagnoses and serological data were retrieved from hospital records. Pixel classification was performed using ilastik, and per-nucleus intensity features were extracted with CellProfiler. Image-level separation was assessed by partitioning nuclei into high- and low-intensity groups via Isolation Forest. Statistical comparisons used Welch's t-tests and Spearman's rank correlation. RESULTS: The AC-30 group included 183 images (AC-1, n = 183; AC-2, n = 207). Within AC-30, 57.4% had non-AID or unknown diagnoses, 26.8% had other autoimmune diseases, and 15.8% had ANA-associated rheumatic disease (AARD). In ENA-negative AC-30, AARD accounted for 7.7% (6/78), compared to 18.3% (21/115) in ENA-negative AC-2. RA accounted for 16.9% (31/183) in AC-30, consistent across ENA strata. AC-30 displayed lower per-nucleus intensities than AC-2 (all p < 0.0001) and reduced per-image ΔMaxIntensity (0.177 vs. 0.252, p < 0.0001), while ΔMeanIntensity was similar (0.068 vs. 0.067, p = 0.549). CONCLUSIONS: AC-30 is quantitatively dimmer than AC-2, with reduced nuclear brightness and peak-intensity separation. In this retrospective cohort, ENA-negative AC-30 was associated with fewer AARD cases. RA accounted for ~17% of AC-30, and anti-CCP and RF remained informative markers. The ilastik-CellProfiler workflow enables auditable ANA quantification.

Journal of Clinical Laboratory Analysis
Shenzhen University (CN), Peking University Shenzhen Hospital (CN), University of Hong Kong (HK)
Openalex Percentile: Top 4%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.